Pernix Therapeutics (PTX) Reports Q2 Loss of $0.47/Share

August 11, 2016 4:23 PM EDT
Get Alerts PTX Hot Sheet
Trade PTX Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

Pernix Therapeutics (NASDAQ: PTX) reported Q2 EPS of ($0.47), versus ($0.62) reported last year. Revenue for the quarter came in at $36.75 million, versus $46.98 million reported last year.

For earnings history and earnings-related data on Pernix Therapeutics (PTX) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment